Clinical trial
Analysis of Anti-inflammatory and Antioxidant Pathways in Lung Diseases by Haem Oxygenase-1 (HO-1) in Induced Sputum and Carbon Monoxide (CO) in Exhaled Air
NCT01140685 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Anti-inflammatory and Antioxidant Pathways in Lung Diseases by Haem Oxygenase-1 (HO-1) in Induced Sputum and Carbon Monoxide (CO) in Exhaled Air
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 31, 2009
- Completion date
- Not reported
- Enrollment
- 70 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.